Practical Management Guide for Clinicians Who Treat Patients with Amiodarone

Academic Article

Abstract

  • © 2016 Elsevier Inc. Amiodarone, an iodinated benzofuran derivative with Class I, II, III, and IV antiarrhythmic properties, is the most commonly used antiarrhythmic drug used to treat supraventricular and ventricular arrhythmias. Appropriate use of this drug, with its severe and potentially life-threatening adverse effects, requires an essential understanding of its risk-benefit properties in order to ensure safety. The objective of this review is to afford clinicians who treat patients receiving amiodarone an appropriate management strategy for its safe use. The authors of this consensus management guide have thoroughly reviewed and evaluated the existing literature on amiodarone and apply this information, along with the collective experience of the authors, in its development. Provided are management guides on the intravenous and oral dosing of amiodarone, appropriate outpatient follow-up of patients taking the drug, its recognized adverse effects, and recommendations on when to consult specialists to help in patient management. All clinicians must be cognizant of the appropriate use, follow-up, and adverse reactions of amiodarone. The responsibility incurred by those treating such patients cannot be overemphasized.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Epstein AE; Olshansky B; Naccarelli GV; Kennedy JI; Murphy EJ; Goldschlager N
  • Start Page

  • 468
  • End Page

  • 475
  • Volume

  • 129
  • Issue

  • 5